SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma.
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Temozolomide (Primary)
- Indications Anaplastic astrocytoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 16 Nov 2008 New trial record.